Your expert team from concept to clinic.

At Leads to Development, we use our knowledge and expertise to help biotechs bring their drugs to and through clinical trials as efficiently as possible, delivering value for companies and life-changing outcomes for patients.

With decades of experience, more than 180 projects under our belt throughout Europe and the US, and a 100% success rate in obtaining clinic trial authorisations, our team provides comprehensive end-to-end support across all areas of new drug development. 

Our backgrounds are in biotech rather than big pharma, so we understand the unique challenges you face on the journey to the clinic. We’re with you every step of the way, from early drug discovery through to market authorisation.

We provide:

• Bespoke development plans designed to meet your goals 
• Regulatory strategies that hit the mark first time - we have a 100% success rate in obtaining clinical trial authorisation, including innovative and ground-breaking products
• Toxicology, pharmacology, production and manufacturing know-how that saves you time and money
• Expert support for scientific advice, pre-IND, CTA, IND, and more
• Clinical oversight to ensure efficient and compliant trial initiation and execution
• Proactive project management from a dedicated team committed to your success

Thanks to our support, many of our clients have achieved successful out-licensing deals or company buyouts, including a recent deal valued at nearly $3 Bn. 

“𝘠𝘰𝘶 𝘢𝘳𝘦 𝘥𝘰𝘪𝘯𝘨 𝘢 𝘨𝘳𝘦𝘢𝘵 𝘫𝘰𝘣! 𝘐𝘵 𝘪𝘴 𝘳𝘦𝘢𝘭𝘭𝘺 𝘯𝘪𝘤𝘦 𝘵𝘰 𝘸𝘰𝘳𝘬 𝘸𝘪𝘵𝘩 𝘵𝘩𝘦 𝘸𝘩𝘰𝘭𝘦 𝘓2𝘋 𝘵𝘦𝘢𝘮, 𝘦𝘷𝘦𝘳𝘺𝘵𝘩𝘪𝘯𝘨 𝘪𝘴 𝘢𝘭𝘸𝘢𝘺𝘴 𝘥𝘦𝘭𝘪𝘷𝘦𝘳𝘦𝘥 𝘰𝘯 𝘵𝘪𝘮𝘦 𝘢𝘯𝘥 𝘷𝘦𝘳𝘺 𝘱𝘳𝘰𝘧𝘦𝘴𝘴𝘪𝘰𝘯𝘢𝘭𝘭𝘺 𝘥𝘰𝘯𝘦" 
- Cécile Bougeret, Vice President Operations at EVEXTA BIO

𝗚𝗲𝘁 𝗶𝗻 𝘁𝗼𝘂𝗰𝗵 𝘁𝗼 𝗱𝗶𝘀𝗰𝘂𝘀𝘀 𝘆𝗼𝘂𝗿 𝗽𝗿𝗼𝗷𝗲𝗰𝘁 𝘁𝗼𝗱𝗮𝘆: contacts@leadstodevelopment.com

Leads To Development

Office 202 focuses on managing and leading preclinical drug development projects, driving innovation in biopharmaceuticals.

Leads To Development

Org chart

Teams

Offices

Leads To Development

Org chart

Teams

Offices

Related companies